Rapid, Successful Response to ART for Many Patients With HIV

This article originally appeared here.
Share this content:
Rapid, Successful Response to ART for Many Patients With HIV
Rapid, Successful Response to ART for Many Patients With HIV

FRIDAY, Sept. 30, 2016 (HealthDay News) -- Many HIV-infected patients have rapid and successful immune and virological response to antiretroviral therapy (ART), according to a study published online Sept. 27 in the Journal of Clinical Pharmacy and Therapeutics.

Marysabel P.T. Silveira, Ph.D., from the Universidade Federal de Pelotas in Brazil, and colleagues conducted a longitudinal observational study involving adult outpatients from a HIV/AIDS clinic. Three hundred thirty-two patients were followed for at least 12 months after enrollment.

The researchers found that 43 percent of patients had indications of stable immune status before starting ART; the median CD4 cell count was 179 cells/mm³ and increased to 379.5 cells/mm³. There was an increase in the proportion of patients with CD4 cell count ≥200 cells/mm³ from 76 to 83 percent, and an increase in undetectable viral load (UVL) from 51.7 to 73 percent. Female gender, pretreatment CD4 count ≥200 cells/mm³, previous UVL, and treatment with three drugs versus four or more correlated with immune success at the end of follow-up. UVL and use of three drugs compared with four or more correlated with virological success.

"These results further support the ongoing need for ongoing programs to increase early HIV testing, early linkage to and treatment with ART, and increased viral suppression," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »